Cyclosporine Treats Severe Poison Ivy in Case Study

JUNE 11, 2014
In a case study presented at the American Academy of Allergy Asthma and Immunology Annual Meeting, researchers successfully treated a 33-year-old patient with yearly, unavoidable poision ivy exposure without using steroids.

Instead, researchers used a 200-mg/day cyclosporine regimen during the patient's exposure period, which resulted in a resolution of poison ivy symptoms after 6 weeks of therapy. The dose was also decreased to 100 mg every other day without the poison ivy symptoms returning, and without the need for topical or systemic corticosteroids.

SHARE THIS SHARE THIS
0

Immunization Laws Around the Nation

Many areas of medicine that intersect with law and immunizations are associated with a very specific set of laws across the nation.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.